Skip to Content
Home > Health Library > Juvenile Idiopathic Arthritis: Features of DMARD and SSARD Drugs
View Additional Content In This Section
Children who have
juvenile idiopathic arthritis (JIA) are first treated
with nonsteroidal anti-inflammatory drugs (NSAIDs) that
often provide relief and reduce inflammation. NSAIDs are considered the
first-line treatment for JIA. Second-line drug therapy—known interchangeably as
disease-modifying antirheumatic drugs (DMARDs) and as slow-acting antirheumatic
drugs (SAARDs)—for JIA may be recommended when a child continues to have joint
pain, swelling, or both despite rest, exercise, use of NSAIDs, and physical
DMARDs/SAARDs include azathioprine,
cyclosporine, etanercept, methotrexate, and sulfasalazine.
a lot in common.
Although these medicines are often called
"disease-modifying," it has been hard to prove that they truly prevent
long-term joint damage. But they often relieve pain and swelling.
June 5, 2012
Susan C. Kim, MD - Pediatrics & John Pope, MD - Pediatrics
How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Request an appointment online>>
2650 Siskiyou Blvd., Medford, OR 97504